data_GLN
#
_chem_comp.id                                        GLN
_chem_comp.name                                      GLUTAMINE
_chem_comp.type                                      "L-PEPTIDE LINKING"
_chem_comp.pdbx_type                                 ATOMP
_chem_comp.formula                                   "C5 H10 N2 O3"
_chem_comp.mon_nstd_parent_comp_id                   ?
_chem_comp.pdbx_synonyms                             ?
_chem_comp.pdbx_formal_charge                        0
_chem_comp.pdbx_initial_date                         1999-07-08
_chem_comp.pdbx_modified_date                        2011-06-04
_chem_comp.pdbx_ambiguous_flag                       N
_chem_comp.pdbx_release_status                       REL
_chem_comp.pdbx_replaced_by                          ?
_chem_comp.pdbx_replaces                             ?
_chem_comp.formula_weight                            146.144
_chem_comp.one_letter_code                           Q
_chem_comp.three_letter_code                         GLN
_chem_comp.pdbx_model_coordinates_details            ?
_chem_comp.pdbx_model_coordinates_missing_flag       N
_chem_comp.pdbx_ideal_coordinates_details            ?
_chem_comp.pdbx_ideal_coordinates_missing_flag       N
_chem_comp.pdbx_model_coordinates_db_code            ?
_chem_comp.pdbx_subcomponent_list                    ?
_chem_comp.pdbx_processing_site                      EBI

#
loop_
_chem_comp_atom.comp_id                        
_chem_comp_atom.atom_id                        
_chem_comp_atom.alt_atom_id                    
_chem_comp_atom.type_symbol                    
_chem_comp_atom.charge                         
_chem_comp_atom.pdbx_align                     
_chem_comp_atom.pdbx_aromatic_flag             
_chem_comp_atom.pdbx_leaving_atom_flag         
_chem_comp_atom.pdbx_stereo_config             
_chem_comp_atom.model_Cartn_x                  
_chem_comp_atom.model_Cartn_y                  
_chem_comp_atom.model_Cartn_z                  
_chem_comp_atom.pdbx_model_Cartn_x_ideal       
_chem_comp_atom.pdbx_model_Cartn_y_ideal       
_chem_comp_atom.pdbx_model_Cartn_z_ideal       
_chem_comp_atom.pdbx_component_atom_id         
_chem_comp_atom.pdbx_component_comp_id         
_chem_comp_atom.pdbx_ordinal                   
GLN    N    N N 0 1 N N N -12.869 34.883 120.983  1.858 -0.148  1.125    N GLN  1
GLN   CA   CA C 0 1 N N S -12.048 35.305 119.985  0.517  0.451  1.112   CA GLN  2
GLN    C    C C 0 1 N N N -10.724 35.797 120.549 -0.236  0.022  2.344    C GLN  3
GLN    O    O O 0 1 N N N  -9.691 35.852 119.806 -0.005 -1.049  2.851    O GLN  4
GLN   CB   CB C 0 1 N N N -12.660 36.476 119.161 -0.236 -0.013 -0.135   CB GLN  5
GLN   CG   CG C 0 1 N N N -13.110 37.658 120.071  0.529  0.421 -1.385   CG GLN  6
GLN   CD   CD C 0 1 N N N -13.701 38.830 119.321 -0.213 -0.036 -2.614   CD GLN  7
GLN  OE1  OE1 O 0 1 N N N -14.715 38.686 118.658 -1.252 -0.650 -2.500  OE1 GLN  8
GLN  NE2  NE2 N 0 1 N N N -13.069 39.999 119.445  0.277  0.236 -3.839  NE2 GLN  9
GLN  OXT  OXT O 0 1 N Y N -10.665 36.169 121.753 -1.165  0.831  2.878  OXT GLN 10
GLN    H    H H 0 1 N N N -13.756 34.553 120.604  1.729 -1.148  1.137    H GLN 11
GLN   H2  HN2 H 0 1 N Y N -13.004 35.604 121.691  2.286  0.078  0.240   H2 GLN 12
GLN   HA   HA H 0 1 N N N -11.902 34.421 119.320  0.605  1.537  1.099   HA GLN 13
GLN  HB2  1HB H 0 1 N N N -11.958 36.821 118.366 -0.324 -1.100 -0.122  HB2 GLN 14
GLN  HB3  2HB H 0 1 N N N -13.496 36.121 118.514 -1.231  0.431 -0.144  HB3 GLN 15
GLN  HG2  1HG H 0 1 N N N -13.818 37.299 120.853  0.617  1.508 -1.398  HG2 GLN 16
GLN  HG3  2HG H 0 1 N N N -12.266 37.994 120.717  1.524 -0.023 -1.375  HG3 GLN 17
GLN HE21 1HE2 H 0 0 N N N -12.221 40.119 119.999 -0.200 -0.058 -4.630 HE21 GLN 18
GLN HE22 2HE2 H 0 0 N N N -13.467 40.789 118.939  1.109  0.727 -3.930 HE22 GLN 19
GLN  HXT  HXT H 0 1 N Y N  -9.838 36.476 122.105 -1.649  0.556  3.669  HXT GLN 20
#
loop_
_chem_comp_bond.comp_id                  
_chem_comp_bond.atom_id_1                
_chem_comp_bond.atom_id_2                
_chem_comp_bond.value_order              
_chem_comp_bond.pdbx_aromatic_flag       
_chem_comp_bond.pdbx_stereo_config       
_chem_comp_bond.pdbx_ordinal             
GLN   N   CA SING N N  1
GLN   N    H SING N N  2
GLN   N   H2 SING N N  3
GLN  CA    C SING N N  4
GLN  CA   CB SING N N  5
GLN  CA   HA SING N N  6
GLN   C    O DOUB N N  7
GLN   C  OXT SING N N  8
GLN  CB   CG SING N N  9
GLN  CB  HB2 SING N N 10
GLN  CB  HB3 SING N N 11
GLN  CG   CD SING N N 12
GLN  CG  HG2 SING N N 13
GLN  CG  HG3 SING N N 14
GLN  CD  OE1 DOUB N N 15
GLN  CD  NE2 SING N N 16
GLN NE2 HE21 SING N N 17
GLN NE2 HE22 SING N N 18
GLN OXT  HXT SING N N 19
#
loop_
_pdbx_chem_comp_descriptor.comp_id               
_pdbx_chem_comp_descriptor.type                  
_pdbx_chem_comp_descriptor.program               
_pdbx_chem_comp_descriptor.program_version       
_pdbx_chem_comp_descriptor.descriptor            
GLN           SMILES              ACDLabs 10.04                                                              O=C(N)CCC(N)C(=O)O
GLN SMILES_CANONICAL               CACTVS 3.341                                                         N[C@@H](CCC(N)=O)C(O)=O
GLN           SMILES               CACTVS 3.341                                                           N[CH](CCC(N)=O)C(O)=O
GLN SMILES_CANONICAL "OpenEye OEToolkits" 1.5.0                                                       C(CC(=O)N)[C@@H](C(=O)O)N
GLN           SMILES "OpenEye OEToolkits" 1.5.0                                                            C(CC(=O)N)C(C(=O)O)N
GLN            InChI                InChI  1.03 InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m0/s1
GLN         InChIKey                InChI  1.03                                                     ZDXPYRJPNDTMRX-VKHMYHEASA-N
#
loop_
_pdbx_chem_comp_identifier.comp_id               
_pdbx_chem_comp_identifier.type                  
_pdbx_chem_comp_identifier.program               
_pdbx_chem_comp_identifier.program_version       
_pdbx_chem_comp_identifier.identifier            
GLN "SYSTEMATIC NAME"              ACDLabs 10.04                             L-glutamine
GLN "SYSTEMATIC NAME" "OpenEye OEToolkits" 1.5.0 "(2S)-2,5-diamino-5-oxo-pentanoic acid"
#
loop_
_pdbx_chem_comp_audit.comp_id               
_pdbx_chem_comp_audit.action_type           
_pdbx_chem_comp_audit.date                  
_pdbx_chem_comp_audit.processing_site       
_pdbx_chem_comp_audit.annotator             
_pdbx_chem_comp_audit.details               
GLN  "Create component" 1999-07-08  EBI ? ?
GLN "Modify descriptor" 2011-06-04 RCSB ? ?
#
_pdbe_chem_comp_drugbank_details.comp_id                   GLN
_pdbe_chem_comp_drugbank_details.drugbank_id               DB00130
_pdbe_chem_comp_drugbank_details.type                      "small molecule"
_pdbe_chem_comp_drugbank_details.name                      L-Glutamine
_pdbe_chem_comp_drugbank_details.description               "A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from glutamic acid and ammonia. It is the principal carrier of nitrogen in the body and is an important energy source for many cells. An oral formulation of L-glutamine was approved by the FDA in July 2017 for use in sickle cell disease [L892]. This oral formulation is marketed under the tradename Endari by Emmaus Medical."
_pdbe_chem_comp_drugbank_details.cas_number                56-85-9
_pdbe_chem_comp_drugbank_details.mechanism_of_action       "Supplemental L-glutamine's possible immunomodulatory role may be accounted for in a number of ways. L-glutamine appears to play a major role in protecting the integrity of the gastrointestinal tract and, in particular, the large intestine. During catabolic states, the integrity of the intestinal mucosa may be compromised with consequent increased intestinal permeability and translocation of Gram-negative bacteria from the large intestine into the body. The demand for L-glutamine by the intestine, as well as by cells such as lymphocytes, appears to be much greater than that supplied by skeletal muscle, the major storage tissue for L-glutamine. L-glutamine is the preferred respiratory fuel for enterocytes, colonocytes and lymphocytes. Therefore, supplying supplemental L-glutamine under these conditions may do a number of things. For one, it may reverse the catabolic state by sparing skeletal muscle L-glutamine. It also may inhibit translocation of Gram-negative bacteria from the large intestine. L-glutamine helps maintain secretory IgA, which functions primarily by preventing the attachment of bacteria to mucosal cells. L-glutamine appears to be required to support the proliferation of mitogen-stimulated lymphocytes, as well as the production of interleukin-2 (IL-2) and interferon-gamma (IFN-gamma). It is also required for the maintenance of lymphokine-activated killer cells (LAK). L-glutamine can enhance phagocytosis by neutrophils and monocytes. It can lead to an increased synthesis of glutathione in the intestine, which may also play a role in maintaining the integrity of the intestinal mucosa by ameliorating oxidative stress. The exact mechanism of the possible immunomodulatory action of supplemental L-glutamine, however, remains unclear. It is conceivable that the major effect of L-glutamine occurs at the level of the intestine. Perhaps enteral L-glutamine acts directly on intestine-associated lymphoid tissue and stimulates overall immune function by that mechanism, without passing beyond the splanchnic bed.  The exact mechanism of L-glutamine's effect on NAD redox potential is unknown but is thought to involve increased amounts of reduced glutathione made available by glutamine supplementation [FDA Label]. This improvement in redox potential reduces the amount of oxidative damage which sickle red blood cells are more susceptible to. The reduction in cellular damage is thought to reduce chronic hemolysis and vaso-occlusive events."

#
_pdbe_chem_comp_drugbank_classification.comp_id           GLN
_pdbe_chem_comp_drugbank_classification.drugbank_id       DB00130
_pdbe_chem_comp_drugbank_classification.parent            "L-alpha-amino acids"
_pdbe_chem_comp_drugbank_classification.kingdom           "Organic compounds"
_pdbe_chem_comp_drugbank_classification.class             "Carboxylic acids and derivatives"
_pdbe_chem_comp_drugbank_classification.superclass        "Organic acids and derivatives"
_pdbe_chem_comp_drugbank_classification.description       "This compound belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom."

#
loop_
_pdbe_chem_comp_drugbank_targets.comp_id                        
_pdbe_chem_comp_drugbank_targets.drugbank_id                    
_pdbe_chem_comp_drugbank_targets.name                           
_pdbe_chem_comp_drugbank_targets.organism                       
_pdbe_chem_comp_drugbank_targets.uniprot_id                     
_pdbe_chem_comp_drugbank_targets.pharmacologically_active       
_pdbe_chem_comp_drugbank_targets.ordinal                        
GLN DB00130               "CTP synthase 1" Humans P17812 unknown 1
GLN DB00130 Amidophosphoribosyltransferase Humans Q06203 unknown 2
GLN DB00130         "Glutamine synthetase" Humans P15104 unknown 3
#
loop_
_pdbx_chem_comp_synonyms.comp_id          
_pdbx_chem_comp_synonyms.name             
_pdbx_chem_comp_synonyms.provenance       
GLN                             L-Glutamine   ChEMBL
GLN                           Levoglutamide   ChEMBL
GLN                              Nutrestore   ChEMBL
GLN                                  Endari   ChEMBL
GLN                               Glutamine   ChEMBL
GLN "(2S)-2-amino-4-carbamoylbutanoic acid" DrugBank
GLN  "(2S)-2,5-diamino-5-oxopentanoic acid" DrugBank
GLN   "(S)-2,5-diamino-5-oxopentanoic acid" DrugBank
GLN                 "Glutamic acid 5-amide" DrugBank
GLN                   "Glutamic acid amide" DrugBank
GLN                               Glutamine DrugBank
GLN                         L-(+)-glutamine DrugBank
GLN              "L-2-aminoglutaramic acid" DrugBank
GLN               "L-glutamic acid Î³-amide" DrugBank
GLN                           Levoglutamide DrugBank
GLN                                       Q DrugBank
#
loop_
_software.name              
_software.version           
_software.description       
       rdkit 2019.03.2                                      "Core functionality."
pdbeccdutils     0.5.2 "Wrapper to provide 2D templates and molecular fragments."
#
loop_
_pdbe_chem_comp_atom_depiction.comp_id             
_pdbe_chem_comp_atom_depiction.atom_id             
_pdbe_chem_comp_atom_depiction.element             
_pdbe_chem_comp_atom_depiction.model_Cartn_x       
_pdbe_chem_comp_atom_depiction.model_Cartn_y       
_pdbe_chem_comp_atom_depiction.pdbx_ordinal        
GLN   N N 3.805  2.340  1
GLN  CA C 5.104  1.590  2
GLN   C C 6.404  2.340  3
GLN   O O 7.702  1.590  4
GLN  CB C 5.104  0.090  5
GLN  CG C 6.404 -0.660  6
GLN  CD C 6.404 -2.160  7
GLN OE1 O 5.104 -2.910  8
GLN NE2 N 7.702 -2.910  9
GLN OXT O 6.404  3.840 10
#
loop_
_pdbe_chem_comp_bond_depiction.comp_id            
_pdbe_chem_comp_bond_depiction.atom_id_1          
_pdbe_chem_comp_bond_depiction.atom_id_2          
_pdbe_chem_comp_bond_depiction.value_order        
_pdbe_chem_comp_bond_depiction.bond_dir           
_pdbe_chem_comp_bond_depiction.pdbx_ordinal       
GLN  N  CA SINGLE BEGINDASH 1
GLN CA   C SINGLE      NONE 2
GLN CA  CB SINGLE      NONE 3
GLN  C   O DOUBLE      NONE 4
GLN  C OXT SINGLE      NONE 5
GLN CB  CG SINGLE      NONE 6
GLN CG  CD SINGLE      NONE 7
GLN CD OE1 DOUBLE      NONE 8
GLN CD NE2 SINGLE      NONE 9
#
loop_
_pdbe_chem_comp_substructure.comp_id                      
_pdbe_chem_comp_substructure.substructure_name            
_pdbe_chem_comp_substructure.id                           
_pdbe_chem_comp_substructure.substructure_type            
_pdbe_chem_comp_substructure.substructure_smiles          
_pdbe_chem_comp_substructure.substructure_inchis          
_pdbe_chem_comp_substructure.substructure_inchikeys       
GLN   amide F1 fragment CC(N)=O InChI=1S/C2H5NO/c1-2(3)4/h1H3,(H2,3,4) DLFVBJFMPXGRIB-UHFFFAOYSA-N
GLN peptide F2 fragment   NCC=O     InChI=1S/C2H5NO/c3-1-2-4/h2H,1,3H2 LYIIBVSRGJSHAV-UHFFFAOYSA-N
#
loop_
_pdbe_chem_comp_substructure_mapping.comp_id                    
_pdbe_chem_comp_substructure_mapping.atom_id                    
_pdbe_chem_comp_substructure_mapping.substructure_id            
_pdbe_chem_comp_substructure_mapping.substructure_ordinal       
GLN NE2 F1 1
GLN  CD F1 1
GLN OE1 F1 1
GLN  CG F1 1
GLN   O F2 1
GLN   C F2 1
GLN  CA F2 1
GLN   N F2 1
#
_pdbe_chem_comp_rdkit_properties.comp_id                               GLN
_pdbe_chem_comp_rdkit_properties.exactmw                               146.069
_pdbe_chem_comp_rdkit_properties.lipinskiHBA                           5
_pdbe_chem_comp_rdkit_properties.lipinskiHBD                           5
_pdbe_chem_comp_rdkit_properties.NumRotatableBonds                     5
_pdbe_chem_comp_rdkit_properties.NumHBD                                3
_pdbe_chem_comp_rdkit_properties.NumHBA                                4
_pdbe_chem_comp_rdkit_properties.NumHeteroatoms                        5
_pdbe_chem_comp_rdkit_properties.NumAmideBonds                         1
_pdbe_chem_comp_rdkit_properties.FractionCSP3                          0.600
_pdbe_chem_comp_rdkit_properties.NumRings                              0
_pdbe_chem_comp_rdkit_properties.NumAromaticRings                      0
_pdbe_chem_comp_rdkit_properties.NumAliphaticRings                     0
_pdbe_chem_comp_rdkit_properties.NumSaturatedRings                     0
_pdbe_chem_comp_rdkit_properties.NumHeterocycles                       0
_pdbe_chem_comp_rdkit_properties.NumAromaticHeterocycles               0
_pdbe_chem_comp_rdkit_properties.NumSaturatedHeterocycles              0
_pdbe_chem_comp_rdkit_properties.NumAliphaticHeterocycles              0
_pdbe_chem_comp_rdkit_properties.NumSpiroAtoms                         0
_pdbe_chem_comp_rdkit_properties.NumBridgeheadAtoms                    0
_pdbe_chem_comp_rdkit_properties.NumAtomStereoCenters                  0
_pdbe_chem_comp_rdkit_properties.NumUnspecifiedAtomStereoCenters       0
_pdbe_chem_comp_rdkit_properties.labuteASA                             72.365
_pdbe_chem_comp_rdkit_properties.tpsa                                  106.410
_pdbe_chem_comp_rdkit_properties.CrippenClogP                          -1.336
_pdbe_chem_comp_rdkit_properties.CrippenMR                             34.040
_pdbe_chem_comp_rdkit_properties.NumHeavyAtoms                         10

#
loop_
_pdbe_chem_comp_external_mappings.comp_id           
_pdbe_chem_comp_external_mappings.source            
_pdbe_chem_comp_external_mappings.resource          
_pdbe_chem_comp_external_mappings.resource_id       
GLN UniChem        ChEMBL        CHEMBL930
GLN UniChem      DrugBank          DB00130
GLN UniChem      DrugBank          DB02174
GLN UniChem "KEGG LIGAND"           C00064
GLN UniChem         ChEBI            18050
GLN UniChem         ChEBI            58359
GLN UniChem          ZINC ZINC000001532526
GLN UniChem          ZINC     ZINC01532526
GLN UniChem     BindingDb            18121
GLN UniChem  MetaboLights       MTBLC18050
GLN UniChem  MetaboLights       MTBLC58359
GLN UniChem        BRENDA              102
GLN UniChem        BRENDA           138052
GLN UniChem        BRENDA           145026
GLN UniChem        BRENDA           145028
GLN UniChem        BRENDA           145942
GLN UniChem        BRENDA              337
GLN UniChem        BRENDA            36640
GLN UniChem        BRENDA              378
GLN UniChem        BRENDA            69708
GLN UniChem        BRENDA              755
GLN UniChem          Rhea            58359
#
loop_
_pdbe_chem_comp_rdkit_conformer.comp_id             
_pdbe_chem_comp_rdkit_conformer.atom_id             
_pdbe_chem_comp_rdkit_conformer.Cartn_x_rdkit       
_pdbe_chem_comp_rdkit_conformer.Cartn_y_rdkit       
_pdbe_chem_comp_rdkit_conformer.Cartn_z_rdkit       
_pdbe_chem_comp_rdkit_conformer.rdkit_method        
_pdbe_chem_comp_rdkit_conformer.rdkit_ordinal       
GLN    N -1.139 -0.964 -1.791 ETKDGv2  1
GLN   CA -1.403 -0.856 -0.352 ETKDGv2  2
GLN    C -2.147  0.413 -0.004 ETKDGv2  3
GLN    O -2.542  0.598  1.179 ETKDGv2  4
GLN   CB -0.096 -1.001  0.456 ETKDGv2  5
GLN   CG  0.923  0.128  0.205 ETKDGv2  6
GLN   CD  2.159  0.002  1.055 ETKDGv2  7
GLN  OE1  2.297 -0.956  1.864 ETKDGv2  8
GLN  NE2  3.192  0.980  0.944 ETKDGv2  9
GLN  OXT -2.411  1.375 -0.975 ETKDGv2 10
GLN    H -2.054 -1.049 -2.291 ETKDGv2 11
GLN   H2 -0.678 -0.093 -2.139 ETKDGv2 12
GLN   HA -2.058 -1.708 -0.064 ETKDGv2 13
GLN  HB2 -0.350 -1.030  1.539 ETKDGv2 14
GLN  HB3  0.373 -1.977  0.199 ETKDGv2 15
GLN  HG2  0.454  1.111  0.420 ETKDGv2 16
GLN  HG3  1.240  0.116 -0.859 ETKDGv2 17
GLN HE21  3.097  1.780  0.280 ETKDGv2 18
GLN HE22  4.055  0.905  1.528 ETKDGv2 19
GLN  HXT -2.911  2.225 -0.742 ETKDGv2 20
#
